Alps Medical Breakthroughs ETF (SBIO) 27.16 $SBIO
Post# of 273254
Posted On: 09/21/2016 9:15:17 PM
Alps Medical Breakthroughs ETF (SBIO) 27.16 $SBIO
Biotech ETFs in Focus on Tobira Therapeutics' Massive Gain
Sanghamitra Saha - Zacks Investment Research - Wed Sep 21, 10:23AM CDT
Tobira Therapeutics surged following the news that Allergan is buying it at an astounding premium and drove several biotech ETFs higher.
BBP: 34.18 (+0.50), AGN: 238.41 (-0.26), SBIO: 27.16 (+0.21), BBC: 22.88 (+0.15), GLMD: 4.64 (+0.03), XBI: 68.28 (+0.77), CNAT: 2.10 (+0.01), ICPT: 168.78 (-1.23), IBB: 297.53 (+1.83)
Inside the Recent Surge in Biotech ETFs
Sanghamitra Saha - Zacks Investment Research - Wed Sep 14, 1:19PM CDT
What caused biotech ETFs to tack on solid gains on September 12.
PBE: 43.30 (+0.30), SBIO: 27.16 (+0.21), PRGO: 93.69 (+0.32), RPTP: 8.99 (+0.02), GILD: 81.70 (-0.08), FBT: 101.90 (+1.11), XBI: 68.28 (+0.77), FOMX: 10.26 (+0.22), HZNP: 19.17 (+0.26), IBB: 297.53 (+1.83)
M&A Activity, Passing Drug Trials Help Biotech ETFs Rebound
editor@etftrends.com (ETF Trends) - ETF Trends - Mon Sep 12, 1:47PM CDT
A large acquisition and favorable results from a drug trial helped biotechnology and pharmaceutical sector-related exchange traded funds rally on Monday. Among the best performing ETFs of Monday, the PowerShares Dynamic Biotech & Genome...
PBE: 43.30 (+0.30), SBIO: 27.16 (+0.21), XPH: 46.27 (+0.15), IBB: 297.53 (+1.83)
Pfizer Acquires Medivation, Renews Biotech M&A Bets
editor@etftrends.com (ETF Trends) - ETF Trends - Mon Aug 22, 1:20PM CDT
Pfizer (NYSE: PFE) announced a $14 billion deal to acquire cancer drug developer Medivation (NasdaqGS: MDVN), propelling the broader biotechnology exchange traded funds higher on speculation of more deals in the sector. Biopharmaceutical giant Pfizer...
PBE: 43.30 (+0.30), SBIO: 27.16 (+0.21), BBC: 22.88 (+0.15), XBI: 68.28 (+0.77)
Biotech ETFs Soar on Pfizer-Anacor Deal: SBIO, XBI in Lead
Sweta Killa - Zacks Investment Research - Tue May 17, 10:40AM CDT
Pfizer struck a deal to acquire the skin drug maker Anacor Pharmaceuticals for $5.2 billion that sent biotech ETFs higher.
AGN: 238.41 (-0.26), PBE: 43.30 (+0.30), SBIO: 27.16 (+0.21), FBT: 101.90 (+1.11), XBI: 68.28 (+0.77), PFE: 34.28 (+0.47), BBH: 118.17 (+0.48), IBB: 297.53 (+1.83), ANAC: 99.06 (-0.14)
Pfizer Acquires Anacor, Reviving M&A Bets in Biotech Sector, ETFs
etftrends@etftrends.com (ETF Trends) - ETF Trends - Mon May 16, 1:41PM CDT
Revitalizing the merger and acquisition outlook for biotech sector exchange traded funds, Pfizer (NYSE: PFE) announced it will buy biopharma company Anacor Pharmaceuticals (NasdaqGS: ANAC). Pfizer paid a 55% premium to Anacor’s closing price...
SBIO: 27.16 (+0.21), XBI: 68.28 (+0.77), IBB: 297.53 (+1.83), XLV: 72.79 (+0.72)
10 Best & Worst ETF Performers of the Day (May 11)
etftrends@etftrends.com (ETF Trends) - ETF Trends - Wed May 11, 4:04PM CDT
Welcome to the ETFtrends.com 10 Best & Worst ETF Performers of the Day for Wednesday, May 11, 2016. 10 Best ETF Performers: Sym Name Last Percent Volume UGA US Gasoline 27.57 +5.55% 93,722 SGG DJ-UBS Sugar TR Sub-Idx ETN Ipath 38.10 +5.02% 62,198...
PBE: 43.30 (+0.30), FBT: 101.90 (+1.11), XBI: 68.28 (+0.77), BNO: 13.82 (+0.34), IBB: 297.53 (+1.83), UGA: 25.94 (+0.77), EPHE: 38.23 (+0.94), XRT: 43.48 (+0.31), SBIO: 27.16 (+0.21), HEWJ: 24.81 (+0.43), GDXJ: 48.04 (+3.57), SLVP: 15.10 (+0.99), DBJP: 32.94 (+0.59), BBH: 118.17 (+0.48), FXD: 35.08 (+0.19), VIXY: 28.81 (-2.45)
ETF TMI: 2 Themed ETFs Launch; Energy, MLPs Active
etftrends@etftrends.com (ETF Trends) - ETF Trends - Tue May 10, 10:00AM CDT
Got a case of TMI (Too Much Information)? ETF Trends takes a condensed look at latest happenings… Global X Launches Longevity and Health & Wellness ETFs on Nasdaq Global X Funds is on a roll, launching two more thematic exchange traded funds...
EEM: 37.85 (+1.03), AMLP: 12.49 (+0.26), SBIO: 27.16 (+0.21), FBT: 101.90 (+1.11), XBI: 68.28 (+0.77), REM: 10.80 (+0.11), XLE: 68.47 (+1.55)
Beyond Miners, 5 ETFs Crushing the Market to Start Q2
Sweta Killa - Zacks Investment Research - Fri Apr 15, 10:33AM CDT
We highlight five ETFs that are crushing the market to start the second quarter and are expected to continue this trend.
USWD: 25.40 (-0.23), SBIO: 27.16 (+0.21), XOP: 36.82 (+1.29), BNO: 13.82 (+0.34), RORO: 40.86 (unch)
The Zacks Analyst Blog Highlights: iShares Nasdaq Biotechnology ETF, SPDR S&P Biotech ETF, ALPS Medical Breakthroughs ETF and BioShares Biotechnology Clinical Trials Fund
Zacks Equity Research - Zacks Investment Research - Tue Feb 02, 8:30AM CST
The Zacks Analyst Blog Highlights: iShares Nasdaq Biotechnology ETF, SPDR S&P Biotech ETF, ALPS Medical Breakthroughs ETF and BioShares Biotechnology Clinical Trials Fund
BBC: 22.88 (+0.15), SBIO: 27.16 (+0.21), XBI: 68.28 (+0.77), IBB: 297.53 (+1.83)
Biotech ETFs Hit 52-Week Lows: Time to Buy?
Sweta Killa - Zacks Investment Research - Mon Feb 01, 8:30AM CST
While investors may want to consider staying on the sidelines given the bearish trend, risk-tolerant long-term investors could consider this slump a buying opportunity.
AGN: 238.41 (-0.26), BIIB: 312.00 (+4.95), BBC: 22.88 (+0.15), SBIO: 27.16 (+0.21), MRK: 62.70 (+0.76), PFE: 34.28 (+0.47), XBI: 68.28 (+0.77), AMGN: 173.85 (+0.47), IBB: 297.53 (+1.83), NVS: 81.52 (+0.46)
The Zacks Analyst Blog Highlights: Market Vectors ChinaAMC SME-ChiNext ETF, WisdomTree Japan Hedged Health Care ETF, ALPS Medical Breakthroughs ETF, PowerShares S&P Small-Cap Energy ETF and InfraCap MLP ETF
Zacks Equity Research - Zacks Investment Research - Thu Dec 31, 8:30AM CST
The Zacks Analyst Blog Highlights: Market Vectors ChinaAMC SME-ChiNext ETF, WisdomTree Japan Hedged Health Care ETF, ALPS Medical Breakthroughs ETF, PowerShares S&P Small-Cap Energy ETF and InfraCap MLP ETF
AMZA: 11.40 (+0.15), SBIO: 27.16 (+0.21), DXJH: 30.44 (unch), CNXT: 32.89 (+0.33), PSCE: 17.02 (+0.60)
Top Sectors of 2015 and Their Leading ETFs
Sweta Killa - Zacks Investment Research - Thu Dec 31, 8:01AM CST
We have highlighted four sectors and their related ETFs that have been the year's star performers and could be better plays into the New Year.
FAN: 13.53 (+0.19), AMZN: 789.74 (+9.52), SBIO: 27.16 (+0.21), FB: 129.94 (+1.30), KBWP: 50.48 (+0.62), FDN: 80.02 (+0.91)
Best & Worst ETFs of 2015
Zacks Equity Research - Zacks Investment Research - Wed Dec 30, 10:21AM CST
Inside the best and worst ETFs of 2015.
AMZA: 11.40 (+0.15), SBIO: 27.16 (+0.21), SPY: 215.82 (+2.40), MOM: 24.10 (unch), DXJH: 30.44 (unch), CNXT: 32.89 (+0.33), ACW: 2.57 (+0.01), BNO: 13.82 (+0.34), COPX: 16.38 (+0.28), FDN: 80.02 (+0.91), BRF: 17.32 (+0.37), PSCE: 17.02 (+0.60)
Biotech ETFs in Focus on Tobira Therapeutics' Massive Gain
Sanghamitra Saha - Zacks Investment Research - Wed Sep 21, 10:23AM CDT
Tobira Therapeutics surged following the news that Allergan is buying it at an astounding premium and drove several biotech ETFs higher.
BBP: 34.18 (+0.50), AGN: 238.41 (-0.26), SBIO: 27.16 (+0.21), BBC: 22.88 (+0.15), GLMD: 4.64 (+0.03), XBI: 68.28 (+0.77), CNAT: 2.10 (+0.01), ICPT: 168.78 (-1.23), IBB: 297.53 (+1.83)
Inside the Recent Surge in Biotech ETFs
Sanghamitra Saha - Zacks Investment Research - Wed Sep 14, 1:19PM CDT
What caused biotech ETFs to tack on solid gains on September 12.
PBE: 43.30 (+0.30), SBIO: 27.16 (+0.21), PRGO: 93.69 (+0.32), RPTP: 8.99 (+0.02), GILD: 81.70 (-0.08), FBT: 101.90 (+1.11), XBI: 68.28 (+0.77), FOMX: 10.26 (+0.22), HZNP: 19.17 (+0.26), IBB: 297.53 (+1.83)
M&A Activity, Passing Drug Trials Help Biotech ETFs Rebound
editor@etftrends.com (ETF Trends) - ETF Trends - Mon Sep 12, 1:47PM CDT
A large acquisition and favorable results from a drug trial helped biotechnology and pharmaceutical sector-related exchange traded funds rally on Monday. Among the best performing ETFs of Monday, the PowerShares Dynamic Biotech & Genome...
PBE: 43.30 (+0.30), SBIO: 27.16 (+0.21), XPH: 46.27 (+0.15), IBB: 297.53 (+1.83)
Pfizer Acquires Medivation, Renews Biotech M&A Bets
editor@etftrends.com (ETF Trends) - ETF Trends - Mon Aug 22, 1:20PM CDT
Pfizer (NYSE: PFE) announced a $14 billion deal to acquire cancer drug developer Medivation (NasdaqGS: MDVN), propelling the broader biotechnology exchange traded funds higher on speculation of more deals in the sector. Biopharmaceutical giant Pfizer...
PBE: 43.30 (+0.30), SBIO: 27.16 (+0.21), BBC: 22.88 (+0.15), XBI: 68.28 (+0.77)
Biotech ETFs Soar on Pfizer-Anacor Deal: SBIO, XBI in Lead
Sweta Killa - Zacks Investment Research - Tue May 17, 10:40AM CDT
Pfizer struck a deal to acquire the skin drug maker Anacor Pharmaceuticals for $5.2 billion that sent biotech ETFs higher.
AGN: 238.41 (-0.26), PBE: 43.30 (+0.30), SBIO: 27.16 (+0.21), FBT: 101.90 (+1.11), XBI: 68.28 (+0.77), PFE: 34.28 (+0.47), BBH: 118.17 (+0.48), IBB: 297.53 (+1.83), ANAC: 99.06 (-0.14)
Pfizer Acquires Anacor, Reviving M&A Bets in Biotech Sector, ETFs
etftrends@etftrends.com (ETF Trends) - ETF Trends - Mon May 16, 1:41PM CDT
Revitalizing the merger and acquisition outlook for biotech sector exchange traded funds, Pfizer (NYSE: PFE) announced it will buy biopharma company Anacor Pharmaceuticals (NasdaqGS: ANAC). Pfizer paid a 55% premium to Anacor’s closing price...
SBIO: 27.16 (+0.21), XBI: 68.28 (+0.77), IBB: 297.53 (+1.83), XLV: 72.79 (+0.72)
10 Best & Worst ETF Performers of the Day (May 11)
etftrends@etftrends.com (ETF Trends) - ETF Trends - Wed May 11, 4:04PM CDT
Welcome to the ETFtrends.com 10 Best & Worst ETF Performers of the Day for Wednesday, May 11, 2016. 10 Best ETF Performers: Sym Name Last Percent Volume UGA US Gasoline 27.57 +5.55% 93,722 SGG DJ-UBS Sugar TR Sub-Idx ETN Ipath 38.10 +5.02% 62,198...
PBE: 43.30 (+0.30), FBT: 101.90 (+1.11), XBI: 68.28 (+0.77), BNO: 13.82 (+0.34), IBB: 297.53 (+1.83), UGA: 25.94 (+0.77), EPHE: 38.23 (+0.94), XRT: 43.48 (+0.31), SBIO: 27.16 (+0.21), HEWJ: 24.81 (+0.43), GDXJ: 48.04 (+3.57), SLVP: 15.10 (+0.99), DBJP: 32.94 (+0.59), BBH: 118.17 (+0.48), FXD: 35.08 (+0.19), VIXY: 28.81 (-2.45)
ETF TMI: 2 Themed ETFs Launch; Energy, MLPs Active
etftrends@etftrends.com (ETF Trends) - ETF Trends - Tue May 10, 10:00AM CDT
Got a case of TMI (Too Much Information)? ETF Trends takes a condensed look at latest happenings… Global X Launches Longevity and Health & Wellness ETFs on Nasdaq Global X Funds is on a roll, launching two more thematic exchange traded funds...
EEM: 37.85 (+1.03), AMLP: 12.49 (+0.26), SBIO: 27.16 (+0.21), FBT: 101.90 (+1.11), XBI: 68.28 (+0.77), REM: 10.80 (+0.11), XLE: 68.47 (+1.55)
Beyond Miners, 5 ETFs Crushing the Market to Start Q2
Sweta Killa - Zacks Investment Research - Fri Apr 15, 10:33AM CDT
We highlight five ETFs that are crushing the market to start the second quarter and are expected to continue this trend.
USWD: 25.40 (-0.23), SBIO: 27.16 (+0.21), XOP: 36.82 (+1.29), BNO: 13.82 (+0.34), RORO: 40.86 (unch)
The Zacks Analyst Blog Highlights: iShares Nasdaq Biotechnology ETF, SPDR S&P Biotech ETF, ALPS Medical Breakthroughs ETF and BioShares Biotechnology Clinical Trials Fund
Zacks Equity Research - Zacks Investment Research - Tue Feb 02, 8:30AM CST
The Zacks Analyst Blog Highlights: iShares Nasdaq Biotechnology ETF, SPDR S&P Biotech ETF, ALPS Medical Breakthroughs ETF and BioShares Biotechnology Clinical Trials Fund
BBC: 22.88 (+0.15), SBIO: 27.16 (+0.21), XBI: 68.28 (+0.77), IBB: 297.53 (+1.83)
Biotech ETFs Hit 52-Week Lows: Time to Buy?
Sweta Killa - Zacks Investment Research - Mon Feb 01, 8:30AM CST
While investors may want to consider staying on the sidelines given the bearish trend, risk-tolerant long-term investors could consider this slump a buying opportunity.
AGN: 238.41 (-0.26), BIIB: 312.00 (+4.95), BBC: 22.88 (+0.15), SBIO: 27.16 (+0.21), MRK: 62.70 (+0.76), PFE: 34.28 (+0.47), XBI: 68.28 (+0.77), AMGN: 173.85 (+0.47), IBB: 297.53 (+1.83), NVS: 81.52 (+0.46)
The Zacks Analyst Blog Highlights: Market Vectors ChinaAMC SME-ChiNext ETF, WisdomTree Japan Hedged Health Care ETF, ALPS Medical Breakthroughs ETF, PowerShares S&P Small-Cap Energy ETF and InfraCap MLP ETF
Zacks Equity Research - Zacks Investment Research - Thu Dec 31, 8:30AM CST
The Zacks Analyst Blog Highlights: Market Vectors ChinaAMC SME-ChiNext ETF, WisdomTree Japan Hedged Health Care ETF, ALPS Medical Breakthroughs ETF, PowerShares S&P Small-Cap Energy ETF and InfraCap MLP ETF
AMZA: 11.40 (+0.15), SBIO: 27.16 (+0.21), DXJH: 30.44 (unch), CNXT: 32.89 (+0.33), PSCE: 17.02 (+0.60)
Top Sectors of 2015 and Their Leading ETFs
Sweta Killa - Zacks Investment Research - Thu Dec 31, 8:01AM CST
We have highlighted four sectors and their related ETFs that have been the year's star performers and could be better plays into the New Year.
FAN: 13.53 (+0.19), AMZN: 789.74 (+9.52), SBIO: 27.16 (+0.21), FB: 129.94 (+1.30), KBWP: 50.48 (+0.62), FDN: 80.02 (+0.91)
Best & Worst ETFs of 2015
Zacks Equity Research - Zacks Investment Research - Wed Dec 30, 10:21AM CST
Inside the best and worst ETFs of 2015.
AMZA: 11.40 (+0.15), SBIO: 27.16 (+0.21), SPY: 215.82 (+2.40), MOM: 24.10 (unch), DXJH: 30.44 (unch), CNXT: 32.89 (+0.33), ACW: 2.57 (+0.01), BNO: 13.82 (+0.34), COPX: 16.38 (+0.28), FDN: 80.02 (+0.91), BRF: 17.32 (+0.37), PSCE: 17.02 (+0.60)
(0)
(0)Scroll down for more posts ▼